絞り込み

16602

広告

「denosumab」の検索結果

2649件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

Denosumab - where does it stand in the GIOP armamentarium?

Bisphosphonates remain a first choice treatment for glucocorticoid-induced osteoporosis: Comment on the Article by Saag et al.

Response to letters: Denosumab Versus Risedronate in Glucocorticoid-Induced Osteoporosis: Final Results of a Twenty-Four-Month Randomized, Double-Blind, Double-Dummy Trial.

Gorham-Stout Syndrome of the Shoulder Girdle Successfully Controlled by Antiresorptive Agents: A Report of 2 Cases.

Anti-osteoporosis Medication Use in a High Fracture-Risk Population: Contemporary Trends in Australian Residential Aged Care Facilities.

Three-level lumbar en bloc spondylectomy with 3D-printed vertebrae reconstruction for recurrent giant cell tumor.

Current Treatments and New Developments in the Management of Glucocorticoid-induced Osteoporosis.

Long-term denosumab treatment restores cortical bone loss and reduces fracture risk at the forearm and humerus: analyses from the FREEDOM Extension cross-over group.

Rebound Vertebral Fractures in a Patient With Lung Cancer After Oncology-Dose Denosumab Discontinuation: A Cautionary Tale.

Severe, Symptomatic Hypocalcemia due to Denosumab Administration: Treatment and Clinical Course.

Expression Profiling of Receptor-Activator of Nuclear Factor-Kappa B Ligand in Soft Tissue Tumors.

Neoadjuvant and Adjuvant Treatment with Denosumab in Aggressive Giant-cell Tumor of Bone in the Proximal Fibula: a Case Report.

Combination of denosumab and immune checkpoint inhibition: experience in 29 patients with metastatic melanoma and bone metastases.

Development of a Practice Standard for Monitoring Adult Patients Receiving Bone-Modifying Agents at a Community Cancer Center.

[Idiopathic bone marrow oedema: Outcome of 3 cases treated with denosumab].

Leukoerythroblastosis in castration-resistant prostate cancer: A clue to diffuse bone marrow carcinomatosis.

Clinical Impact of RANK Signalling in Ovarian Cancer.

Management of osteoporosis in the Middle East and North Africa: a survey of physicians' perceptions and practices.

Fracture risk following intermission of osteoporosis therapy.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
Sort by
※並べ替えは表示に時間がかかります